Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrazinone derivatives for use in MCH-1 mediated diseases

Substituted pyrazinone derivatives for use in MCH-1 mediated diseases

US Patent 8329704 · Granted Dec 11, 2012

Estimated economic value: $42,605,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tau PET imaging ligands2024
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipe2023
FOXP3-binding peptides and uses thereof2023
Tau PET imaging ligands2021
Radiolabelled mGluR2/3 PET ligands2021
Radiolabelled mGluR2/3 pet ligands2021
Radiolabelled mGluR2 PET ligands2021
Radiolabelled mGluR2 PET ligands2021
FoxP3-binding peptides and uses thereof2020
1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives2020
Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulator2020
6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative 2019